Professor Justin Stebbing On Vaccine Breakthroughs And Herd-Immunity By Summer
Macro Hive Conversations With Bilal Hafeez · Bilal Hafeez
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This episode is supported by private equity platform Moonfare.
In this show, I talk with Professor Justin Stebbing. I had him as a guest in July when he argued that we could see a COVID vaccine around US election time. He was right and so I wanted to get his latest views. For background, Justin is a professor in the Faculty of Medicine at Imperial college London. He specializes in cancers and immunotherapies. He has an extensive research background having published over 550 peer-reviewed papers. Earlier this year, he published in the Lancet new research on using AI to find drugs to treat COVID-19 and recently published in Foreign Affairs China's global role in vaccine distribution. In this podcast we discuss:
- The significance of Pfizer's 90% efficacy rate
- Vaccines from other pharma companies including from Russia & China
- The science of vaccines – B-cell and T-cell responses
- Fast tracking of vaccine approval by FDA
- Managing public opinion and anti-vaxxers
- Logistics of vaccine distribution
- When will we get to herd-immunity
- Remaining uncertainties around vaccines
- Mink factories and mutations
- Long COVID and athletes
- Which countries have secured vaccine supplies